Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation (Q66395971)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation |
clinical trial |
Statements
A Randomized Phase 2 Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation (English)
0 references
29 November 2016
0 references
February 2020
0 references
200
0 references
18 year
0 references